Compare MESO & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | USAS |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | Australia | Canada |
| Employees | 81 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | N/A | 2004 |
| Metric | MESO | USAS |
|---|---|---|
| Price | $14.27 | $4.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 175.9K | ★ 4.0M |
| Earning Date | 02-26-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $629.74 | $174.68 |
| Revenue Next Year | $30.65 | $53.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.32 | $0.85 |
| 52 Week High | $21.50 | $10.50 |
| Indicator | MESO | USAS |
|---|---|---|
| Relative Strength Index (RSI) | 49.97 | 43.25 |
| Support Level | $13.91 | $4.60 |
| Resistance Level | $16.06 | $5.12 |
| Average True Range (ATR) | 0.40 | 0.34 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 47.08 | 24.23 |
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.